MET and non-small cell lung carcinoma: We reveal here that disturbing lipid raft integrity inhibits the activation of c-Met and its downstream pathways, increases the sensitivity of NSCLC cells to radiotherapy, enhances the therapeutic ratio, and thus provides a new strategy to address the radio-resistance of NSCLC cells.